Student Name
Capella University
NURS-FPX4015 Pathophysiology, Pharmacology, and Physical Assessment: A Holistic Approach to Patient-Centered Care
Prof. Name
Date
Concept Map: The 3Ps and Mental Health Care
Major Depressive Disorder (MDD) is a pervasive mental health condition that significantly impacts individuals worldwide, ranking as the third leading contributor to the global burden of disease (Bains & Abdijadid, 2023). Effective management of MDD requires an understanding of three key influencing factors—psychological, physiological, and pharmacological—collectively referred to as the 3Ps. This conceptual framework supports clinicians in developing evidence-based, personalized care plans that address the multifactorial nature of depression, optimize treatment outcomes, and enhance patient-centered care.
Case Scenario
Who is Ivy Jackson and what are her presenting symptoms?
Ivy Jackson is a 61-year-old woman presenting with classic features of Major Depressive Disorder following the end of her 38-year marriage. Her symptoms include persistent sadness, emotional distress, disrupted sleep, and unintentional weight loss. These manifestations meet the criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) for MDD. Comprehensive evaluation of Ivy’s risk factors, diagnostic tests, medication history, potential complications, and nursing interventions is necessary to develop an effective care plan.
Mental Health Diagnosis
What are Ivy Jackson’s clinical symptoms and their significance?
Ivy demonstrates hallmark symptoms of Major Depressive Disorder, such as anhedonia, fatigue, impaired cognition, and insomnia (Bains & Abdijadid, 2023). The dissolution of her long-term marriage has precipitated profound psychological distress, including hopelessness and social withdrawal. She has experienced a 10-pound weight loss due to reduced appetite, accompanied by fatigue and difficulty concentrating. Although she denies suicidal ideation, her emotional isolation elevates the risk of further complications, necessitating continuous assessment and psychosocial support.
What factors contribute to Ivy’s depressive episode?
Multiple factors exacerbate Ivy’s depression. Psychosocial stressors, such as her recent divorce, a family history of depression, and current social isolation, are significant contributors. Genetic predisposition is relevant, given that both her mother and brother have histories of depression. Her medical history includes hypertension and prior depressive episodes during stressful life transitions, such as her youngest child leaving home. Previously, Ivy was prescribed venlafaxine (an SNRI), but she discontinued it due to withdrawal-related distress. Research highlights that non-adherence to antidepressant treatment strongly correlates with the recurrence of depressive episodes (Naudín et al., 2022).
How does Ivy’s depression differ from situational depression?
While her depressive episode was initially triggered by the divorce, her condition extends beyond situational depression, which typically resolves when the stressor abates. MDD is characterized by persistent symptoms, underlying biological dysfunctions such as neurotransmitter imbalances, and dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis (Remes, 2021). Therefore, Ivy’s condition necessitates a comprehensive treatment strategy encompassing pharmacological therapy, psychotherapy, and lifestyle modifications to promote adherence, improve quality of life, and reduce the risk of relapse.
Concept Map for Ivy Jackson
What are the key psychological, physiological, and pharmacological factors in Ivy’s case?
| Factors | Psychological | Physiological | Pharmacological |
|---|---|---|---|
| Risk Factors | Divorce, family history of depression, social isolation | Hypertension, previous depressive episodes | Discontinuation of venlafaxine, medication non-adherence |
| Signs & Symptoms | Persistent sadness, hopelessness, crying, anhedonia | Fatigue, weight loss, sleep disruption, poor appetite | Antidepressant side effects, withdrawal symptoms |
| Diagnostics | DSM-5 criteria for MDD | Thyroid function tests, complete blood count (CBC), Vitamin D screening | History of medication response, adherence patterns |
| Complications | Chronic depression, social isolation, cognitive impairment | Poorly controlled hypertension, nutritional deficiencies | Relapse due to non-compliance, treatment resistance |
| Nursing Interventions | Cognitive Behavioral Therapy (CBT), Interpersonal Therapy, enhancing social support | Sleep hygiene education, diet consultation, promotion of exercise | Patient education on medication use, side effect management, adherence monitoring |
Conclusion
Ivy Jackson’s case highlights the multifactorial complexity of Major Depressive Disorder. Employing the 3Ps framework—psychological, physiological, and pharmacological—offers a structured approach for identifying risk factors, evaluating clinical manifestations, guiding diagnostic assessments, and implementing effective interventions. Successful management of MDD extends beyond symptom relief to include addressing underlying contributors, promoting adherence, and supporting overall mental health. A holistic, patient-centered strategy integrating psychotherapy, medical management, and lifestyle interventions is essential to facilitate Ivy’s recovery and long-term well-being.
References
Bains, N., & Abdijadid, S. (2023, April 10). Major depressive disorder. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK559078/
Chand, S., & Arif, H. (2023). Depression. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK430847/
NURS FPX 4015 Assessment 3 Concept Map: The 3Ps and Mental Health Care
Lieshout, R. J. V., Layton, H., Savoy, C. D., Haber, E., Feller, A., Biscaro, A., Bieling, P. J., & Ferro, M. A. (2022). Public health nurse-delivered group cognitive behavioural therapy for postpartum depression: A randomized controlled trial. The Canadian Journal of Psychiatry, 67(6), 432–440. https://doi.org/10.1177/07067437221074426
Naudín, M. A.-P., Abejón, E.-G., Gómez, F.-H., Lázaro, D.-F., & Álvarez, F. J. (2022). Non-adherence to antidepressant treatment and related factors in a region of Spain: A population-based registry study. Pharmaceutics, 14(12), 2696. https://doi.org/10.3390/pharmaceutics14122696
Remes, O. (2021). Biological, psychological, and social determinants of depression: A review of recent literature. Brain Sciences, 11(12), 1–33. https://doi.org/10.3390/brainsci11121633